TAMPA, Fla., Nov. 8, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology platform company, operates as a national Third-Party Administrator (TPA) through its subsidiaries. We're transforming the $22 billion TPA market by offering affordable, intelligent, healthcare solutions to self-funded employer health plans. The Company will host a conference call and webcast on Tuesday, November 12 at 8:30 a.m. ET to present the Company's operational and financial highlights for its third quarter 2024. The Company will report its third quarter results on Monday after the market close.
Event: | Marpai Third Quarter Financial Results Conference Call |
Date: | November 12, 2024 |
Time: | 8:30 a.m. Eastern Time |
Call: | US: 1-646-357-8785 / Toll Free: 1-800-836-8184 |
Webcast: |
To instantly join the conference call by phone, please use the following link to easily register close to the call start time. After registering, the system will call you instantly and connect you into the conference call automatically: https://emportal.ink/4f2qTxJ
Alternatively, you may dial in to the conference call by calling 1-646-357-8785 or 1-800-836-8184 and you will be connected to the call by an Operator.
You may also stream the call by Webcast by following this link: https://app.webinar.net/Jd298rR8DBe. The webcast replay will be available at the same URL within 2 hours of the end of the call. A replay of the call will be available within 2 hours of the end of the call until November 19, 2024 by calling 1-646-517-4150 or 1-888-660-6345 and entering the replay code, 07499 #.
About Marpai, Inc.
Marpai, Inc. (OTCQX: MRAI) is a technology platform company which operates subsidiaries that provide TPA and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the $22 billion TPA sector serving self-funded employer health plans representing over $1 trillion in annual claims. Marpai works to deliver the healthiest member population for the health plan budget. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna and all TPA services. For more information, visit https://ir.marpaihealth.com the content of which is not incorporated by reference into this press release.
Last Trade: | US$1.25 |
Daily Change: | -0.11 -8.09 |
Daily Volume: | 480 |
Market Cap: | US$18.620M |
May 14, 2025 May 13, 2025 March 18, 2025 January 06, 2025 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load